Cargando…
Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours
OBJECTIVE: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) encompass a diverse group of neoplasms that vary in their secretory products and in their location within the gastrointestinal tract. Their prevalence in the USA is increasing among all adult age groups. AIM: To identify the possibl...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576490/ https://www.ncbi.nlm.nih.gov/pubmed/34750164 http://dx.doi.org/10.1136/bmjgast-2021-000765 |
_version_ | 1784595887164489728 |
---|---|
author | Rico, Karen Duan, Suzann Pandey, Ritu L Chen, Yuliang Chakrabarti, Jayati T Starr, Julie Zavros, Yana Else, Tobias Katona, Bryson W Metz, David C Merchant, Juanita L |
author_facet | Rico, Karen Duan, Suzann Pandey, Ritu L Chen, Yuliang Chakrabarti, Jayati T Starr, Julie Zavros, Yana Else, Tobias Katona, Bryson W Metz, David C Merchant, Juanita L |
author_sort | Rico, Karen |
collection | PubMed |
description | OBJECTIVE: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) encompass a diverse group of neoplasms that vary in their secretory products and in their location within the gastrointestinal tract. Their prevalence in the USA is increasing among all adult age groups. AIM: To identify the possible derivation of GEP-NETs using genome-wide analyses to distinguish small intestinal neuroendocrine tumours, specifically duodenal gastrinomas (DGASTs), from pancreatic neuroendocrine tumours. DESIGN: Whole exome sequencing and RNA-sequencing were performed on surgically resected GEP-NETs (discovery cohort). RNA transcript profiles available in the Gene Expression Omnibus were analysed using R integrated software (validation cohort). Digital spatial profiling (DSP) was used to analyse paraffin-embedded GEP-NETs. Human duodenal organoids were treated with 5 or 10 ng/mL of tumor necrosis factor alpha (TNFα) prior to qPCR and western blot analysis of neuroendocrine cell specification genes. RESULTS: Both the discovery and validation cohorts of small intestinal neuroendocrine tumours induced expression of mesenchymal and calcium signalling pathways coincident with a decrease in intestine-specific genes. In particular, calcium-related, smooth muscle and cytoskeletal genes increased in DGASTs, but did not correlate with MEN1 mutation status. Interleukin 17 (IL-17) and tumor necrosis factor alpha (TNFα) signalling pathways were elevated in the DGAST RNA-sequencing. However, DSP analysis confirmed a paucity of immune cells in DGASTs compared with the adjacent tumour-associated Brunner’s glands. Immunofluorescent analysis showed production of these proinflammatory cytokines and phosphorylated signal transducer and activator of transcription 3 (pSTAT3) by the tumours and stroma. Human duodenal organoids treated with TNFα induced neuroendocrine tumour genes, SYP, CHGA and NKX6.3. CONCLUSIONS: Stromal–epithelial interactions induce proinflammatory cytokines that promote Brunner’s gland reprogramming. |
format | Online Article Text |
id | pubmed-8576490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-85764902021-11-19 Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours Rico, Karen Duan, Suzann Pandey, Ritu L Chen, Yuliang Chakrabarti, Jayati T Starr, Julie Zavros, Yana Else, Tobias Katona, Bryson W Metz, David C Merchant, Juanita L BMJ Open Gastroenterol Neuroendocrine Tumours OBJECTIVE: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) encompass a diverse group of neoplasms that vary in their secretory products and in their location within the gastrointestinal tract. Their prevalence in the USA is increasing among all adult age groups. AIM: To identify the possible derivation of GEP-NETs using genome-wide analyses to distinguish small intestinal neuroendocrine tumours, specifically duodenal gastrinomas (DGASTs), from pancreatic neuroendocrine tumours. DESIGN: Whole exome sequencing and RNA-sequencing were performed on surgically resected GEP-NETs (discovery cohort). RNA transcript profiles available in the Gene Expression Omnibus were analysed using R integrated software (validation cohort). Digital spatial profiling (DSP) was used to analyse paraffin-embedded GEP-NETs. Human duodenal organoids were treated with 5 or 10 ng/mL of tumor necrosis factor alpha (TNFα) prior to qPCR and western blot analysis of neuroendocrine cell specification genes. RESULTS: Both the discovery and validation cohorts of small intestinal neuroendocrine tumours induced expression of mesenchymal and calcium signalling pathways coincident with a decrease in intestine-specific genes. In particular, calcium-related, smooth muscle and cytoskeletal genes increased in DGASTs, but did not correlate with MEN1 mutation status. Interleukin 17 (IL-17) and tumor necrosis factor alpha (TNFα) signalling pathways were elevated in the DGAST RNA-sequencing. However, DSP analysis confirmed a paucity of immune cells in DGASTs compared with the adjacent tumour-associated Brunner’s glands. Immunofluorescent analysis showed production of these proinflammatory cytokines and phosphorylated signal transducer and activator of transcription 3 (pSTAT3) by the tumours and stroma. Human duodenal organoids treated with TNFα induced neuroendocrine tumour genes, SYP, CHGA and NKX6.3. CONCLUSIONS: Stromal–epithelial interactions induce proinflammatory cytokines that promote Brunner’s gland reprogramming. BMJ Publishing Group 2021-11-08 /pmc/articles/PMC8576490/ /pubmed/34750164 http://dx.doi.org/10.1136/bmjgast-2021-000765 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Neuroendocrine Tumours Rico, Karen Duan, Suzann Pandey, Ritu L Chen, Yuliang Chakrabarti, Jayati T Starr, Julie Zavros, Yana Else, Tobias Katona, Bryson W Metz, David C Merchant, Juanita L Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours |
title | Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours |
title_full | Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours |
title_fullStr | Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours |
title_full_unstemmed | Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours |
title_short | Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours |
title_sort | genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours |
topic | Neuroendocrine Tumours |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576490/ https://www.ncbi.nlm.nih.gov/pubmed/34750164 http://dx.doi.org/10.1136/bmjgast-2021-000765 |
work_keys_str_mv | AT ricokaren genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours AT duansuzann genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours AT pandeyritul genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours AT chenyuliang genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours AT chakrabartijayatit genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours AT starrjulie genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours AT zavrosyana genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours AT elsetobias genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours AT katonabrysonw genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours AT metzdavidc genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours AT merchantjuanital genomeanalysisidentifiesdifferencesinthetranscriptionaltargetsofduodenalversuspancreaticneuroendocrinetumours |